About 1 result found for searched term "2367004-54-2" (0.119 seconds)
Cat.No. | Name | Target |
---|---|---|
M11240 | Zanzalintinib | TAM Receptor |
XL092; JUN04542 | ||
Zanzalintinib (XL092) is an orally active, ATP-competitive inhibitor of multireceptor tyrosine kinases (RTKs), including MET, VEGFR2, AXL and MER, with IC50 values of 15 nM, 1.6 nM, 3.4 nM and 7.2 nM in cell analysis, respectively. XL092 has antitumor activity. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.